Cuba Has Made At Least 3 Major Medical Innovations That We Need
By most measures, the United States' business-friendly environment has proven to be fertile for medical innovation. Compared to other countries, America has filed the most patents in the life sciences, is conducting most of the world's clinical trials and has published the most biomedical research. That's what makes the medical prominence of Cuba all the more surprising to those who view a free market as an essential driver of scientific discovery. Cuba is very poor, and yet the country has some of the healthiest, most long-lived residents in the world -- as well as a medical invention or two that could run circl...
Source: Science - The Huffington Post - March 15, 2016 Category: Science Source Type: news

New Findings Show Anti-Tumor Activity of KEYTRUDA ® (pembrolizumab) in Patients with Advanced Nasopharyngeal Carcinoma
< div class= " field field-type-text field-field-press-release-city field-fieldpressreleasecity " > < div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " > KENILWORTH, N.J. < /div > < /div > < /div > < div class= " field field-type-text field-field-press-release-subheadline field-fieldpressreleasesubheadline " > < div class= " field-items " > < div class= " field-item odd " > < p > KEYTRUDA Monotherapy Achieved Overall Response Rate of 22.2 Percent in Previously-Treated Patients < /p > < p > Results from KEYNOTE-028 ...
Source: Merck.com - Product News - September 26, 2015 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News Source Type: news

New Findings Show Anti-Tumor Activity of KEYTRUDA® (pembrolizumab) in Patients with Advanced Nasopharyngeal Carcinoma
Dateline City: KENILWORTH, N.J. KEYTRUDA Monotherapy Achieved Overall Response Rate of 22.2 Percent in Previously-Treated Patients Results from KEYNOTE-028 Presented at 2015 European Cancer Congress KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the first-time presentation of findings investigating the use of KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, as a monotherap...
Source: Merck.com - Corporate News - September 26, 2015 Category: Pharmaceuticals Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News Source Type: news

Data in Nine Difficult-to-Treat Cancers from Merck ’s KEYTRUDA® (pembrolizumab) Development Program to be Presented at European Cancer Congress 2015, Including Data in Four New Cancer Types: ...
< div class= " field field-type-text field-field-press-release-city field-fieldpressreleasecity " > < div class= " field-label " > Dateline City: < /div > < div class= " field-items " > < div class= " field-item odd " > KENILWORTH, N.J. < /div > < /div > < /div > < div class= " field field-type-text field-field-press-release-subheadline field-fieldpressreleasesubheadline " > < div class= " field-items " > < div class= " field-item odd " > < p > ...Nasopharyngeal Carcinoma, Anal Cancer, Merkel Cell Carcinoma and Biliary Tract Cancer < /p > < p > Data to Include First-Time Findings...
Source: Merck.com - Product News - September 21, 2015 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Research and Development News Corporate News Latest News Source Type: news

Data in Nine Difficult-to-Treat Cancers from Merck’s KEYTRUDA® (pembrolizumab) Development Program to be Presented at European Cancer Congress 2015, Including Data in Four New Cancer Types: ...
Dateline City: KENILWORTH, N.J. ...Nasopharyngeal Carcinoma, Anal Cancer, Merkel Cell Carcinoma and Biliary Tract Cancer Data to Include First-Time Findings on the Potential Importance of PD-L2 Expression in Predicting Patient Responsiveness to Anti-PD-1 Therapy KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new data investigating the anti-tumor activity of KEYTRUDA® (pembr...
Source: Merck.com - Product News - September 21, 2015 Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Research and Development News Corporate News Latest News Source Type: news

Heartbreak as young father told the lumps on his neck were due to an infection discovers he has terminal cancer after GOOGLING his symptoms
Tom Cooper, 28, from Burnley, has been diagnosed with a terminal form of Nasopharyngeal Carcinoma. He is cared for by his wife, Tammy, 26, and daughters: Tienna, seven, and Ziani, four. (Source: the Mail online | Health)
Source: the Mail online | Health - May 13, 2015 Category: Consumer Health News Source Type: news

Engineered cells could help tackle the third most common cancer in Chinese males
(University of Birmingham) Researchers at the University of Birmingham believe that a new method of genetically engineering immune cells could lead to improved treatment of Nasopharyngeal carcinoma patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 10, 2015 Category: Cancer & Oncology Source Type: news

CDC: 2009 to 2017 Saw Increase in Oral Cavity, Pharynx Cancers
Incidence dropped for cancers of lip, floor of mouth, soft palate and uvula, hard palate, hypopharynx, nasopharynx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 11, 2014 Category: Cancer & Oncology Tags: Family Medicine, Internal Medicine, Oncology, ENT, Pathology, Journal, Source Type: news

Risk for Cancer Increased in Men, Women With T2DM
Standardized incidence ratio highest for prostate cancer for men, nasopharynx cancer for women (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 11, 2014 Category: Cancer & Oncology Tags: Dermatology, Endocrinology, Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Nephrology, Oncology, ENT, Pulmonology, Urology, Journal, Source Type: news

Potential avenues for treatment of deadly nasopharyngeal cancer discovered
A distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer have been found by an international team of researchers, paving the way to developing novel therapies for this deadly disease. The group has conducted the first successful comprehensive genomic study of nasopharyngeal carcinoma, which has a particularly high prevalence in Southern China and Southeast Asia, including Singapore. The findings provide an enhanced road map for the study of the molecular basis of this form of cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 23, 2014 Category: Science Source Type: news

New study offers potential avenues for treatment of deadly nasopharyngeal cancer
(National University of Singapore) A team of scientists from the Cancer Science Institute of Singapore at the National University of Singapore, National University Cancer Institute Singapore and National University Hospital Singapore, discovered a distinct mutational signature and nine significantly mutated genes associated with nasopharyngeal cancer, paving the way to developing novel therapies for this deadly disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 23, 2014 Category: Cancer & Oncology Source Type: news

Mother-of-two prescribed ear drops for hearing loss discovers she has a huge cancerous tumour growing behind her face
Claire Hessan, 39, from Cornwall, was diagnosed with nasopharyngeal cancer a year after first visiting the doctor complaining of hearing loss, a strange itch in her ear and lumps in her neck. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2014 Category: Consumer Health News Source Type: news

Pamela Youde Nethersole Eastern Hospital First in Asia to Treat Cancer using TrueBeam 2.0 System for Image-Guided Radiotherapy and Radiosurgery
New technology now being used to treat nasopharyngeal and other cancers; stereotactic radiosurgery program for select cancers coming in June HONG KONG, May 19, 2014 -- (Healthcare Sales & Marketing Network) -- Pamela Youde Nethersole Eastern Hospital (... Devices, OncologyVarian Medical Systems, radiosurgery, radiotherapy, TrueBeam (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 19, 2014 Category: Pharmaceuticals Source Type: news

Nasopharyngeal Cancer
Title: Nasopharyngeal CancerCategory: Diseases and ConditionsCreated: 4/23/2008 12:00:00 AMLast Editorial Review: 4/2/2014 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 2, 2014 Category: Cancer & Oncology Source Type: news

Smoking reduces nasopharyngeal cancer survival
Both current and former smoking have a significant impact on the prognosis of patients with nasopharyngeal carcinoma, Chinese researchers caution. (Source: MedWire News - Oncology)
Source: MedWire News - Oncology - November 27, 2013 Category: Cancer & Oncology Source Type: news